Sprout, an easy, in-browser tool for creating Flash applications, is about to launch publicly. The company has been generating buzz since it launched in January, and chief executive Carnet Williams ...

Valeant Pharmaceuticals will pay about $1 billion to buy Sprout Pharmaceuticals, the maker of the first prescription drug designed to boost sexual desire in women. (Ryan Remiorz/The Canadian Press via ...

Sprout, the startup behind an easy-to-use tool for creating Flash applications, has been having a very good year. It launched in January at DEMO (where it snagged a “DEMO god” award), made its app ...

(Reuters) - Canada's Valeant Pharmaceuticals International Inc <VRX.TO> <VRX.N> said on Thursday it would buy Sprout Pharmaceuticals, which makes a controversial new drug to treat low sexual desire in ...

RALEIGH — Sprout Pharmaceuticals has sold options and securities in a debt round to raise more than $8.1 million, according to a regulatory filing. Sprout makes the FDA-approved female sexual ...

The ink is hardly dry on the approval letter from the Food and Drug Administration, but the makers of Addyi, the “Female Viagra,” have decided it’s time to cash out. Canadian-based Valeant ...

Valeant Pharmaceuticals International Inc. agreed to pay about $1 billion in cash for Sprout Pharmaceuticals Inc., the U.S. drugmaker that this week received approval to sell a pill for low libido in ...